The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
V | Various | |
2
|
V08 | Contrast media | |
3
|
V08A | X-ray contrast media, iodinated | |
4
|
V08AA | Watersoluble, nephrotropic, high osmolar X-ray contrast media |
| Code | Title | |
|---|---|---|
| V08AA01 | Diatrizoic acid | |
| V08AA02 | Metrizoic acid | |
| V08AA03 | Iodamide | |
| V08AA04 | Iotalamic acid | |
| V08AA05 | Ioxitalamic acid | |
| V08AA06 | Ioglicic acid | |
| V08AA07 | Acetrizoic acid | |
| V08AA08 | Iocarmic acid | |
| V08AA09 | Methiodal | |
| V08AA10 | Diodone |
| Active Ingredient |
|---|
|
|
|
|
|
Iotalamic acid is intended for use as a diagnostic radiopaque medium. It is used in excretory urography, cerebral angiography, peripheral arteriography, venography, arthrography, direct cholangiography, endoscopic retrograde cholangiopancreatography, contrast enhancement of computed tomographic brain images, cranial computerized angiotomography, intravenous digital subtraction angiography and arterial digital subtraction angiography. |
|
|
| Document | Type | Information Source | |
|---|---|---|---|
| CONRAY Solution for injection | MPI, US: SPL/Old | FDA, National Drug Code (US) | |
| CYSTO-CONRAY II Solution for injection | MPI, US: SPL/Old | FDA, National Drug Code (US) | |
| GASTROGRAFIN Gastroenteral solution | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| UROGRAFIN Solution for infusion | MPI, EU: SmPC | Health Products Regulatory Authority (IE) |